A Company Built to Meet the Needs of the Industry

Founded in 1998 by Daniel M. Perlman, RPS built an innovative new business model specifically to address the anticipated challenges facing the biopharmaceutical industry:

• Tougher regulatory environment demanding increased QUALITY
• Increasing COST pressures and need for enhanced EFFICIENCIES
• Biopharmaceutical and Device and Diagnostic Industries desire to retain strategic CONTROL of core competencies
• Increased GLOBALIZATION of clinical trials